Cholinergic Receptor, Nicotinic, alpha 5 (Neuronal) (CHRNA5) Peptide
-
- Target See all CHRNA5 products
- CHRNA5 (Cholinergic Receptor, Nicotinic, alpha 5 (Neuronal) (CHRNA5))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- DGSQVDIILE DQDVDKRDFF DNGEWEIVSA TGSKGNRTDS CCWYPYVTYS
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CHRNA5 antibody,
Alternative Names: CHRNA5 control peptide, CHRNA5 antibody Blocking Peptide, Anti-CHRNA5 Blocking Peptide, Cholinergic Receptor Nicotinic Alpha 5 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- CHRNA5 (Cholinergic Receptor, Nicotinic, alpha 5 (Neuronal) (CHRNA5))
- Background
- Nicotinic acetylcholine receptors (nAChRs), such as CHRNA5, are members of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. The nAChRs are thought to be (hetero)pentamers composed of homologous subunits.
- Molecular Weight
- 53 kDa
-